Market Pulse Tech headlines rippled through ETFs and small caps, propelled by Belpointe Asset...
Archive - September 15, 2025
OLMA: Analysts see “Moderate Buy”—Is it time to act?
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) – now also referred to as Olema Oncology – is a clinical...
“AGI: Why Alamos Gold is set to soar this quarter!”
Company Overview Alamos Gold Inc. (NYSE/TSX: AGI) is a Canadian-based intermediate gold producer...
KALA: Price Target Soars to $33—Get In Before It’s Too Late!
Company Overview & Recent Developments KALA BIO, Inc. (NASDAQ: KALA) is a clinical-stage...